Astec LifeSciences Limited
Quick Take
- • Trading at n/a trailing earnings (66.1× forward)
- • Moderate ROE at -17.0%
- • Leveraged balance sheet (D/E 1.15)
- • No dividend data
- • Operating margin -14.0% · Net margin -15.1%
- • Profit growth — YoY · Beta 0.17
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 84 | -47.17% | -30.00% |
| Operating Profit | 0 | -100.00% | -100.00% |
| Net Profit | -19 | -137.50% | -18.75% |
| EPS (₹) | -8.40 | -141.38% | -2.44% |
About the company
From latest AR & concallAstec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservatives. It also provides herbicides, insecticides, and agrochemical intermediates. The company also exports its products. Further, it offers contract development and manufacturing operations. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited operates as a subsidiary of Godrej Agrovet Limited.
